MENU
About Us
Mission & Objectives
Meet Our DIGICORE Community
Membership
Join Now
Members
Associate Members
Bylaws
Activities
Connect to Win
Training activities
Working Groups
Seminar Series
Projects
Publications
Posters
Governance
Board of Directors
General Assembly
Executive Team
Academic Research Management
Commercial Research Management
General Management
News & Events
Contact
Restricted Area
Skip Navigation Links
Posters
OHDSI 2026
Changes in HER2 status between primary and metastatic disease in HR+ metastatic breast cancer highlights the clinical requirement for re-biopsy at relapse in the DigiONE OMOP federated oncology network
OHDSI 2025
The Minimal Essential Description of Cancer (MEDOC) facilitates high-quality Real-World Evidence across a European cancer network
OHDSI 2025
"Studyathons" can catalyse rapid progress in OMOP-enabled oncology research: insights from DigiONE
EACR 2025
Building precision oncology via real-world data standardization, privacy preserving infrastructures, and collaboration among IT and clinical experts: The DIGICORE experience
OHDSI 2024
Clinically validated line of therapy (LoT) algorithm for patients with metastatic non-small cell lung cancer (mNSCLC) can be implemented using systemic anti-cancer therapy (SACT) in Observational Medical Outcomes Partnership (OMOP) database
OHDSI 2024
Harmonization of routine care data from hospitals in the Digital Oncology Network for Europe (DigiONE) into Observational Medical Outcomes Partnership (OMOP) databases reveals changes in the number of new primary cancers diagnosed and 12-month survival during COVID-19 lockdowns
ESMO 2024
Federated analysis of overall survival (OS) by location of metastasis in patients with metastatic non-small cell lung cancer (mNSCLC) from the Digital Oncology Network for Europe (DigiONE)